Manufacturer record
Nestor Pharmaceuticals Limited 11: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Nestor Pharmaceuticals Limited 11 (Haryana) were declared Not of Standard Quality between January 2020 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Nestor Pharmaceuticals Limited 11 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP (500 mg+125mg | CVTC-815Mfg 2025-09 · Exp 2027-08 | Content of Clavulanic AcidOther | GORAKHPUR LAB, UPState lab | Jul 2026 |
| Oral Rehydration Salts IP ORS Powder | ODSC-667Mfg 2025-07 · Exp 2027-06 | Sample does not conform to IP standards with respect to Assay of Potassium.Assay | DTL ThrissurState lab | Feb 2026 |
| Atorvastatin Tablets IP 20 mg | STTC-06Mfg 2025-03 · Exp 2027-02 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab | Oct 2025 |
| Albendazole Tablets IP 400 MG | ABTW-05Mfg 2019-01 · Exp 2021-12 | DissolutionDissolution | RDTL ChandigarhState lab | Jan 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.